Journal Article

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

Punga, Tanel, Sabre, Liis, Punga, Anna Rostedt

2020

Overview

Myasthenia gravis (MG) is an autoimmune disease caused by antibodies which attack receptors at the neuromuscular junction. One of the main difficulties in predicting the clinical course of MG is the heterogeneity of the disease, where disease progression differs greatly depending on the subgroup that the patient is classified into. MG subgroups are classified according to: age of onset [early-onset MG (EOMG; onset ≤ 50 years) late-onset MG (LOMG; onset > 50 years]; the presence of a thymoma (thymoma-associated MG); antibody subtype [acetylcholine receptor antibody seropositive (AChR+) and muscle-specific tyrosine kinase antibody seropositive (MuSK+)]; as well as clinical subtypes (ocular generalized MG). The diagnostic tests for MG, such as antibody titers, neurophysiological tests, and objective clinical fatigue score, do not necessarily reflect disease progression. Hence, there is a great need for reliable objective biomarkers in MG to follow the disease course as well as the individualized response to therapy toward personalized medicine. In this regard, circulating microRNAs (miRNAs) have emerged as promising potential biomarkers due to their accessibility in body fluids and unique profiles in different diseases, including autoimmune disorders. Several studies on circulating miRNAs in MG subtypes have revealed specific miRNA profiles in patients' sera. In generalized AChR+ EOMG, miR-150-5p and miR-21-5p are the most elevated miRNAs, with lower levels observed upon treatment with immunosuppression and thymectomy. In AChR+ generalized LOMG, the miR-150-5p, miR-21-5p, and miR-30e-5p levels are elevated and decrease in accordance with the clinical response after immunosuppression. In ocular MG, higher levels of miR-30e-5p discriminate patients who will later generalize from those remaining ocular. In contrast, in MuSK+ MG, the levels of the let-7 miRNA family members are elevated. Studies of circulating miRNA profiles in Lrp4 or agrin antibody-seropositive MG are still lacking. This review summarizes the present knowledge of circulating miRNAs in different subgroups of MG.

• Publisher: Frontiers Media SA,Frontiers Media S.A
• Subject: Age / Agrin / Antibodies / Autoimmune diseases / biomarker / Biomarkers / Biomarkers - blood / Body fluids / circulating microRNA / Circulating MicroRNA - blood / Disease / Humans / Immunology / Immunosuppression / Kinases / Medical diagnosis / MicroRNAs / MicroRNAs - metabolism / miR-150-5p / miR-21-5p / miR-30e-5p / miRNA / Muscle fatigue / Musculoskeletal system / Myasthenia gravis / Myasthenia Gravis - blood / Myasthenia Gravis - classification / Myasthenia Gravis - therapy / Neuromuscular junctions / Obesity / Patients / Precision medicine / Precision Medicine - methods / Proteins / Receptor Protein-Tyrosine Kinases - metabolism / Receptors, Cholinergic - metabolism / Thymectomy / Thymoma / Thymus gland